Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2012, Article ID 497614, 4 pages
http://dx.doi.org/10.1155/2012/497614
Case Report

Successful Treatment of Posttransplant EBV-Associated Lymphoma and Plasmacytoma Solely Localized to the CNS

1Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, 2730 Herlev, Denmark
2Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, 2730 Herlev, Denmark

Received 18 November 2011; Accepted 10 December 2011

Academic Editors: R. Herrmann, M.-C. Kyrtsonis, and S. Storti

Copyright © 2012 Per Boye Hansen and Signe Ledou Nielsen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Gottschalk, C. M. Rooney, and H. E. Heslop, “Post-transplant lymphoproliferative disorders,” Annual Review of Medicine, vol. 56, pp. 29–44, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. A. Parker, K. Bowles, J. A. Bradley et al., “Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients—BCSH and BTS Guidelines,” British Journal of Haematology, vol. 149, no. 5, pp. 693–705, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. S. Choquet, V. Leblond, R. Herbrecht et al., “Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study,” Blood, vol. 107, no. 8, pp. 3053–3057, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. J. S. Knight, A. Tsodikov, D. M. Cibrik, C. W. Ross, M. S. Kaminski, and D. W. Blayney, “Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center,” Journal of Clinical Oncology, vol. 27, no. 20, pp. 3354–3362, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. C. M. Rooney, C. A. Smith, C. Y. C. Ng et al., “Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients,” Blood, vol. 92, no. 5, pp. 1549–1555, 1998. View at Google Scholar · View at Scopus
  6. S. Caillard, C. Lelong, F. Pessione, and B. Moulin, “Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French registry,” American Journal of Transplantation, vol. 6, no. 11, pp. 2735–2742, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. G. Opelz and B. Döhler, “Lymphomas after solid organ transplantation: a collaborative transplant study report,” American Journal of Transplantation, vol. 4, no. 2, pp. 222–230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Rubenstein, D. Combs, J. Rosenberg et al., “Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment,” Blood, vol. 101, no. 2, pp. 466–468, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. C. G. Brunstein, D. J. Weisdorf, T. DeFor et al., “Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation,” Blood, vol. 108, no. 8, pp. 2874–2880, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. L. Kordelas, R. Trenschel, M. Koldehoff, A. Elmaagacli, and D. W. Beelen, “Successful treatment of EBV PTLD with CNS lymphomas with the monoclonal anti-CD20 antibody rituximab,” Onkologie, vol. 31, no. 12, pp. 691–693, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. M. Hänel, F. Fiedler, and C. Thorns, “Anti-CD20 monoclonal antibody (Rituximab) and cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement,” Onkologie, vol. 24, no. 5, pp. 491–494, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. S. L. Petersen, A. Wagner, and P. Gimsing, “Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature,” American Journal of Hematology, vol. 62, no. 4, pp. 228–233, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Nieuwenhuizen and D. H. Biesma, “Central nervous system myelomatosis: review of the literature,” European Journal of Haematology, vol. 80, no. 1, pp. 1–9, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. A. Wavre, A. S. Baur, M. Betz et al., “Case study of intracerebral plasmacytoma as an initial presentation of multiple myeloma,” Neuro-Oncology, vol. 9, no. 3, pp. 370–372, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus